Mixed cytomegalovirus genotypes in HIV positive mothers show compartmentalization and distinct patterns of transmission to infants

  1. Juanita Pang
  2. Jennifer A Slyker
  3. Sunando Roy
  4. Josephine Bryant
  5. Claire Atkinson
  6. Juliana Cudini
  7. Carey Farquhar
  8. Paul Griffiths
  9. James Kiarie
  10. Sofia Morfopoulou
  11. Alison C Roxby
  12. Helena Tutil
  13. Rachel Williams
  14. Soren Gantt
  15. Richard A Goldstein
  16. Judith Breuer  Is a corresponding author
  1. University College London, United Kingdom
  2. University of Washington, United States
  3. University College of London, United Kingdom
  4. University of Nairobi, Kenya
  5. University of Montréal, Canada

Abstract

Cytomegalovirus (CMV) is the commonest cause of congenital infection (cCMVi) and particularly so among infants born to HIV-infected women. Studies of cCMVi pathogenesis are complicated by the presence of multiple infecting maternal CMV strains, especially in HIV-positive women, and the large, recombinant CMV genome. Using newly developed tools to reconstruct CMV haplotypes, we demonstrate anatomic CMV compartmentalization in five HIV-infected mothers and identify the possibility of congenitally transmitted genotypes in three of their infants. A single CMV strain was transmitted in each congenitally infected case, and all were closely related to those that predominate in the cognate maternal cervix. Compared to non-transmitted strains, these congenitally transmitted CMV strains showed statistically significant similarities in 19 genes associated with tissue-tropism and immunomodulation. In all infants, incident superinfections with distinct strains from breast milk were captured during follow-up. The results represent potentially important new insights into the virologic determinants of early CMV infection.

Data availability

Sequence reads have been deposited in NCBI Sequence Read Archive under BioProject ID PRJNA605798.

Article and author information

Author details

  1. Juanita Pang

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  2. Jennifer A Slyker

    Department of Global Health, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Sunando Roy

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  4. Josephine Bryant

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  5. Claire Atkinson

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  6. Juliana Cudini

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  7. Carey Farquhar

    Departments of Global Health, Epidemiology, Medicine (Div. Allergy and Infectious Diseases), University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Paul Griffiths

    University College of London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  9. James Kiarie

    Department of Obstetrics and Gynaecology, University of Nairobi, Nairobi, Kenya
    Competing interests
    The authors declare that no competing interests exist.
  10. Sofia Morfopoulou

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Alison C Roxby

    Department of Global Health, University of Washington, Seattle, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Helena Tutil

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  13. Rachel Williams

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  14. Soren Gantt

    Infectious Diseases and Immunology, University of Montréal, Montréal, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5743-3606
  15. Richard A Goldstein

    Division of Infection and Immunity, University College London, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5148-4672
  16. Judith Breuer

    Division of Infection and Immunity, University College London, London, United Kingdom
    For correspondence
    j.breuer@ucl.ac.uk
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8246-0534

Funding

EUFP7 (304875)

  • Judith Breuer

UCL/UCLH NIHR Biomedical Research Centre

  • Judith Breuer

Sir Henry Wellcome Fellowship

  • Sofia Morfopoulou

Sir Henry Wellcome Fellowships

  • Josephine Bryant

Wellcome Trust (204870)

  • Paul Griffiths

NIH National Institute of Allergy and Infectious Diseases (AI087369)

  • Jennifer A Slyker

NIH National Institute of Allergy and Infectious Diseases (AI027757)

  • Jennifer A Slyker

NIH National Institute of Allergy and Infectious Diseases (AI076105)

  • Carey Farquhar

NIH National Institute of Allergy and Infectious Diseases (AI087399)

  • Carey Farquhar

National Institute of Child Health and Human Development (HD057773-01)

  • Carey Farquhar

National Institute of Child Health and Human Development (HD054314)

  • Carey Farquhar

Rosetreees Trust PhD Studentship (M876)

  • Juanita Pang

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Pang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,136
    views
  • 166
    downloads
  • 19
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Juanita Pang
  2. Jennifer A Slyker
  3. Sunando Roy
  4. Josephine Bryant
  5. Claire Atkinson
  6. Juliana Cudini
  7. Carey Farquhar
  8. Paul Griffiths
  9. James Kiarie
  10. Sofia Morfopoulou
  11. Alison C Roxby
  12. Helena Tutil
  13. Rachel Williams
  14. Soren Gantt
  15. Richard A Goldstein
  16. Judith Breuer
(2020)
Mixed cytomegalovirus genotypes in HIV positive mothers show compartmentalization and distinct patterns of transmission to infants
eLife 9:e63199.
https://doi.org/10.7554/eLife.63199

Share this article

https://doi.org/10.7554/eLife.63199

Further reading

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Iti Mehta, Jacob B Hogins ... Larry Reitzer
    Research Article

    Polyamines are biologically ubiquitous cations that bind to nucleic acids, ribosomes, and phospholipids and, thereby, modulate numerous processes, including surface motility in Escherichia coli. We characterized the metabolic pathways that contribute to polyamine-dependent control of surface motility in the commonly used strain W3110 and the transcriptome of a mutant lacking a putrescine synthetic pathway that was required for surface motility. Genetic analysis showed that surface motility required type 1 pili, the simultaneous presence of two independent putrescine anabolic pathways, and modulation by putrescine transport and catabolism. An immunological assay for FimA—the major pili subunit, reverse transcription quantitative PCR of fimA, and transmission electron microscopy confirmed that pili synthesis required putrescine. Comparative RNAseq analysis of a wild type and ΔspeB mutant which exhibits impaired pili synthesis showed that the latter had fewer transcripts for pili structural genes and for fimB which codes for the phase variation recombinase that orients the fim operon promoter in the ON phase, although loss of speB did not affect the promoter orientation. Results from the RNAseq analysis also suggested (a) changes in transcripts for several transcription factor genes that affect fim operon expression, (b) compensatory mechanisms for low putrescine which implies a putrescine homeostatic network, and (c) decreased transcripts of genes for oxidative energy metabolism and iron transport which a previous genetic analysis suggests may be sufficient to account for the pili defect in putrescine synthesis mutants. We conclude that pili synthesis requires putrescine and putrescine concentration is controlled by a complex homeostatic network that includes the genes of oxidative energy metabolism.

    1. Genetics and Genomics
    Yi Li, Long Gong ... Shangbang Gao
    Research Article

    Resistance to anthelmintics, particularly the macrocyclic lactone ivermectin (IVM), presents a substantial global challenge for parasite control. We found that the functional loss of an evolutionarily conserved E3 ubiquitin ligase, UBR-1, leads to IVM resistance in Caenorhabditis elegans. Multiple IVM-inhibiting activities, including viability, body size, pharyngeal pumping, and locomotion, were significantly ameliorated in various ubr-1 mutants. Interestingly, exogenous application of glutamate induces IVM resistance in wild-type animals. The sensitivity of all IVM-affected phenotypes of ubr-1 is restored by eliminating proteins associated with glutamate metabolism or signaling: GOT-1, a transaminase that converts aspartate to glutamate, and EAT-4, a vesicular glutamate transporter. We demonstrated that IVM-targeted GluCls (glutamate-gated chloride channels) are downregulated and that the IVM-mediated inhibition of serotonin-activated pharynx Ca2+ activity is diminished in ubr-1. Additionally, enhancing glutamate uptake in ubr-1 mutants through ceftriaxone completely restored their IVM sensitivity. Therefore, UBR-1 deficiency-mediated aberrant glutamate signaling leads to ivermectin resistance in C. elegans.